Once-daily administration of amlodipine, a long-acting dihydropyridine calcium-channel
blocker, and atenolol, a cardioselective [beta]-adrenoceptor blocking agent, were compared …

Amlodipine, a new long-acting dihydropyridine calcium antagonist, was compared with
placebo and atenolol in 125 patients with mild to moderate systemic hypertension [supine …

To determine the dose-response efficacy of once-daily administration of placebo or a new
long-acting calcium channel blocker amlodipine in patients with mild to moderate …

The efficacy and safety of amlodipine (2.5 mg, 5 mg, or 10 mg) once daily was compared
with atenolol (50 mg to 100 mg) once daily in patients with mildto-moderate essential …

Amlodipine is a new long-acting calcium antagonist that has a long half-life and appears to
be suitable for once-daily administration. A double-blind, randomized, parallel, placebo …

One hundred sixty patients with mild to moderate essential hypertension entered this double-
blind parallel group comparison of amlodipine, verapamil, and placebo. Sixteen centers …

The efficacy and safety of amlodipine (2.5–10 mg) once daily was compared with atenolol
(50–100 mg) once daily in patients with mild-to-moderate essential hypertension in a …

A multicenter, placebo-controlled trial assessed the antihypertensive efficacy and safety of
different doses of amlodipine in patients with mild to moderate hypertension. Amlodipine …

The antihypertensive efficacy and safety of amlodipine was evaluated in an open,
multicenter general practice study. Hypertensive patients with sitting diastolic blood pressure …

The antihypertensive efficacy of once-daily amlodipine was studied in a group of 30 patients
with mild to moderate hypertension in a double-blind, placebo-controlled, parallel-group …